Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Palo Alto Networks (PANW) Reiterated at Overweight by Cantor Fitzgerald on Revenue Beat
-
Okta (OKTA) Reiterated at Overweight by Cantor Fitzgerald as New Products Drive Beat
-
Fortinet (FTNT) Reiterated at Neutral by Cantor Fitzgerald on 'Strongest Beats'
-
JFrog (FROG) Reiterated at Overweight by Cantor Fitzgerald on Revenue Beat
-
CrowdStrike (CRWD) Reiterated at Overweight by Cantor Fitzgerald on Modest Beat
-
Nuvation Bio prices $250M convertible notes offering due 2032
-
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
-
Form NPORT-P Cantor Fitzgerald Commod For: Apr 30
-
Helus Pharma closes $50M share offering at $4.85 per share
-
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
-
Quince Therapeutics (QNCX) Reiterated at Overweight by Cantor Fitzgerald
-
Quince Therapeutics (QNCX) Reiterated at Overweight by Cantor Fitzgerald Post Orphai Acquisition
-
Veradermics (MANE) Reiterated at Overweight by Cantor Fitzgerald After Investor Dinner
-
Eupraxia Pharmaceuticals (EPRX) Reiterated at Overweight by Cantor Fitzgerald
-
NuCube Energy to go public via SPAC deal valued at $500M
-
NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.
-
Primoris Services Corporation (PRIM) PT Lowered to $100 at Cantor Fitzgerald Post Webcast
-
Micron Technology (MU) Reiterated at Overweight by Cantor Fitzgerald
-
ARS Pharmaceuticals (SPRY) Reiterated at Overweight by Cantor Fitzgerald
-
COPT Defense Properties (CDP) Reiterated at Overweight by Cantor Fitzgerald
-
Nuvation Bio plans $200M convertible notes offering due 2032
-
Nuvation Bio Announces Proposed Convertible Senior Notes Offering
-
Qualcomm (QCOM) PT Raised to $220 at Cantor Fitzgerald
-
ProQR prices $50M share offering with Eli Lilly joining as buyer
-
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
-
Taysha Gene Therapies prices $200M public stock offering
-
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
-
Cantor Equity Partners I, Inc. Announces Postponement of Shareholder Meeting to 10:00 Am Eastern Time July 2, 2026
-
Taysha Gene Therapies launches $200M stock and warrant offering
-
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Continental Stock Transfer & Trust Selects Securitize as Preferred Tokenization Provider
-
Tenax Therapeutics (TENX) Reiterated at Overweight by Cantor Fitzgerald: Ph3 Data in Q3
-
Cantor Fitzgerald Reiterates Neutral Rating on Quantum Computing, Inc. (QUBT)
-
Cantor Fitzgerald Starts Silence Therapeutics (SLN) at Overweight
-
Helus Pharma prices $50M share offering at $4.85 per share
-
Helus Pharma™ Announces US$50 Million Underwritten Offering
-
Helus Pharma™ Announces US$50 Million Underwritten Offering
-
MoonLake prices $200 million public offering at $20 per share
-
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
-
Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald on Negative SV Data
-
Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald after Analyst Call
-
Primoris Services Corporation (PRIM) Reiterated at Neutral by Cantor Fitzgerald
-
Crescent Biopharma (CBIO) Reiterated at Overweight by Cantor Fitzgerald
-
Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised
-
Cantor Fitzgerald Starts Factorial Energy (FAC) at Overweight
-
Cantor Fitzgerald Starts Quince Therapeutics Inc. (QNCX) at Overweight
-
Wilco 63 Corporation Completes $230,000,000 Initial Public Offering
-
MoonLake proposes $150M public offering of Class A shares
-
MoonLake Immunotherapeutics Announces Proposed Public Offering
-
Robinhood Markets (HOOD) PT Raised to $130 at Cantor Fitzgerald

